Atom Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Sell
58,642
-91,656
-61% -$610K 0.04% 565
2026
Q1
$819K Buy
150,298
+129,988
+640% +$729K 0.06% 390
2025
Q4
$142K Sell
20,310
-67,625
-77% -$529K 0.01% 516
2025
Q3
$680K Buy
87,935
+66,564
+311% +$520K 0.05% 312
2025
Q2
$186K Buy
+21,371
New +$155K 0.02% 520
2024
Q2
Sell
-20,854
Closed -$315K 663
2024
Q1
$315K Buy
+20,854
New +$378K 0.04% 402
2023
Q1
Sell
-12,401
Closed -$293K 317
2022
Q4
$293K Buy
+12,401
New +$334K 0.15% 140
2022
Q3
Sell
-10,106
Closed -$336K 362
2022
Q2
$336K Buy
+10,106
New +$429K 0.15% 140
2022
Q1
Sell
-6,155
Closed -$565K 309
2021
Q4
$565K Buy
+6,155
New +$736K 0.09% 152
2019
Q1
Sell
-12,092
Closed -$738K 706
2018
Q4
$599K Buy
+12,092
New +$740K 0.06% 405

Other funds holding TDOC

Atom Investors's TDOC Position: Q2 2026 in Review

Atom Investors reduced its Teladoc Health (TDOC) stake by 61% in Q2 2026, selling an estimated $610K and leaving 58,642 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #565.

Atom Investors first reported a position in TDOC in Q4 2018 and has held it in 10 quarters since. The position peaked at $819K in Q1 2026. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Atom Investors held 58,642 shares of Teladoc Health worth $497K as of Q2 2026.
  • Atom Investors sold 91,656 Teladoc Health shares in Q2 2026, an estimated $610K.
  • Teladoc Health made up 0.04% of Atom Investors's portfolio in Q2 2026, its #565 holding.
  • Atom Investors first reported a position in Teladoc Health in Q4 2018 and has held it in 10 quarters since.
  • Atom Investors's Teladoc Health position peaked at $819K in Q1 2026.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.